Profitability
Weight: 20%
C
54
- 5yr Avg ROIC 5.3%
- Operating Margin Trend +1.63 pp/yr
TEVA
Teva Pharmaceutical Industries Limited
AlphaQuality composite grade, weighted for stable earnings power businesses.
⚠ 3 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.
Grade overrides the 30.0 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
14
- 5yr Avg ROE -7.1%
- 5yr Share-Count CAGR 1.5%
Growth Quality
Weight: 15%
B-
64
- 5yr Revenue CAGR 2.1%
- 5yr EPS CAGR 33.3%
- Revenue-Growth Years (5) 3/5
Cash Generation
Weight: 15%
C+
57
- 5yr FCF Margin 5.0%
- 5yr FCF/NI Conversion 0.69x
Balance Sheet
Weight: 20%
F
24
- Net Debt / EBITDA 4.40x
- Interest Coverage (EBIT/Int) 2.34x
- Altman Z-Score 0.90
Stability
Weight: 15%
D+
40
- EPS Volatility (σ/μ) 0.92
- Piotroski F-Score 7
- Negative-Revenue Years (5) 2/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.4 of 5 gurus held; 3 added; 1 trimmed; 2 full exits.
- Holders
- 4 -1
- Avg Δ position
- +1387.5%
- New buys
- 0
- Full exits
- 2